ACPU
ZBH icon

Arrowgrass Capital Partners (US)’s Zimmer Biomet ZBH Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,300
Closed -$109M – 538
2015
Q2 		$109M Buy
+10,300
New +$1.14M 1.62% 10

Other funds holding ZBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s ZBH Position: Q3 2015 in Review

Arrowgrass Capital Partners (US) sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 265,890 shares — an estimated $28.2M sold.

Arrowgrass Capital Partners (US) first reported a position in ZBH in Q4 2013 and held it in 5 quarters. The position peaked at $39.8M in Q1 2015. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

  • Arrowgrass Capital Partners (US) reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 265,890 Zimmer Biomet shares in Q3 2015, an estimated $28.2M.
  • Arrowgrass Capital Partners (US) first reported a position in Zimmer Biomet in Q4 2013 and held it in 5 quarters.
  • Arrowgrass Capital Partners (US)'s Zimmer Biomet position peaked at $39.8M in Q1 2015.
  • 725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2015, filed 16 Nov 2015.